Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319072895> ?p ?o ?g. }
- W4319072895 endingPage "27" @default.
- W4319072895 startingPage "20" @default.
- W4319072895 abstract "Reliable predictive markers are lacking for resectable non-small cell lung cancer (NSCLC) patients treated with neoadjuvant chemoimmunotherapy. The present study investigated the utility of SUVmax values acquired from PET/CT to predict the response to neoadjuvant chemoimmunotherapy for resectable NSCLC.SUVmax, clinical and pathological outcomes, were collected from patients in 5 hospitals. Patients who received dynamic PET/CT surveillance were divided into cohorts A (chemoimmunotherapy) and B (chemotherapy), respectively, while cohort C (chemoimmunotherapy) comprised patients undergoing post-therapy PET/CT. Associations between SUVmax and major pathologic response (MPR) were evaluated through receiver operating characteristic (ROC) curves.A total of 129 cases with an MPR rate of 46.5 % was identified. In neoadjuvant chemoimmunotherapy, ΔSUVmax% (AUC: 0.890, 95 % CI: 0.761-0.949) and post-therapy SUVmax (AUC: 0.933, 95 % CI: 0.802-0.959) could accurately predict MPR. On the contrary, the baseline SUVmax was not associated with MPR (p = 0.184). Furthermore, an independent cohort C proved that post-therapy SUVmax could serve as an independent predictor (AUC: 0.928, 95 % CI: 0.823-0.958). In addition, robust predictive performance could be observed when we use the optimal cut-off point of both ΔSUVmax% (54.4 %, AUC: 0.912, 95 % CI: 0.824-0.994) and post-therapy SUVmax (3.565, AUC: 0.912, 95 % CI: 0.824-0.994) in neoadjuvant chemoimmunotherapy. The RNA data revealed that the expression of PFKFB4, a key enzyme in glycolysis, was positively correlated with SUVmax value and tumor cell proliferation after neoadjuvant chemoimmunotherapy.These findings highlighted that the ΔSUVmax% and remained SUVmax were accurate and non-invasive tests for the prediction of MPR after neoadjuvant chemoimmunotherapy." @default.
- W4319072895 created "2023-02-04" @default.
- W4319072895 creator A5003853120 @default.
- W4319072895 creator A5015963155 @default.
- W4319072895 creator A5016353454 @default.
- W4319072895 creator A5025041105 @default.
- W4319072895 creator A5028340973 @default.
- W4319072895 creator A5029779593 @default.
- W4319072895 creator A5034997659 @default.
- W4319072895 creator A5039404681 @default.
- W4319072895 creator A5042748825 @default.
- W4319072895 creator A5045542419 @default.
- W4319072895 creator A5049351697 @default.
- W4319072895 creator A5053138993 @default.
- W4319072895 creator A5068750928 @default.
- W4319072895 creator A5069771802 @default.
- W4319072895 creator A5071798264 @default.
- W4319072895 creator A5083003250 @default.
- W4319072895 date "2023-04-01" @default.
- W4319072895 modified "2023-10-15" @default.
- W4319072895 title "Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer" @default.
- W4319072895 cites W1493048246 @default.
- W4319072895 cites W2062883767 @default.
- W4319072895 cites W2097347992 @default.
- W4319072895 cites W2098720660 @default.
- W4319072895 cites W2134291074 @default.
- W4319072895 cites W2141551796 @default.
- W4319072895 cites W2148991525 @default.
- W4319072895 cites W2412180449 @default.
- W4319072895 cites W2726503501 @default.
- W4319072895 cites W2742282063 @default.
- W4319072895 cites W2795845948 @default.
- W4319072895 cites W2798160602 @default.
- W4319072895 cites W2805293507 @default.
- W4319072895 cites W2805365897 @default.
- W4319072895 cites W2867613812 @default.
- W4319072895 cites W2883477253 @default.
- W4319072895 cites W2884100356 @default.
- W4319072895 cites W2911201777 @default.
- W4319072895 cites W2943492451 @default.
- W4319072895 cites W2945057866 @default.
- W4319072895 cites W2988625390 @default.
- W4319072895 cites W3001895421 @default.
- W4319072895 cites W3003197494 @default.
- W4319072895 cites W3006038212 @default.
- W4319072895 cites W3021010739 @default.
- W4319072895 cites W3024979278 @default.
- W4319072895 cites W3033779930 @default.
- W4319072895 cites W3041397352 @default.
- W4319072895 cites W3083646467 @default.
- W4319072895 cites W3089266118 @default.
- W4319072895 cites W3117368271 @default.
- W4319072895 cites W3124323992 @default.
- W4319072895 cites W3133221794 @default.
- W4319072895 cites W3138152895 @default.
- W4319072895 cites W3155981164 @default.
- W4319072895 cites W3169520674 @default.
- W4319072895 cites W3195215840 @default.
- W4319072895 cites W3208109801 @default.
- W4319072895 cites W3209855730 @default.
- W4319072895 cites W4210360326 @default.
- W4319072895 cites W4226382697 @default.
- W4319072895 cites W4285395831 @default.
- W4319072895 cites W4302305298 @default.
- W4319072895 doi "https://doi.org/10.1016/j.lungcan.2023.02.001" @default.
- W4319072895 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36764154" @default.
- W4319072895 hasPublicationYear "2023" @default.
- W4319072895 type Work @default.
- W4319072895 citedByCount "2" @default.
- W4319072895 countsByYear W43190728952023 @default.
- W4319072895 crossrefType "journal-article" @default.
- W4319072895 hasAuthorship W4319072895A5003853120 @default.
- W4319072895 hasAuthorship W4319072895A5015963155 @default.
- W4319072895 hasAuthorship W4319072895A5016353454 @default.
- W4319072895 hasAuthorship W4319072895A5025041105 @default.
- W4319072895 hasAuthorship W4319072895A5028340973 @default.
- W4319072895 hasAuthorship W4319072895A5029779593 @default.
- W4319072895 hasAuthorship W4319072895A5034997659 @default.
- W4319072895 hasAuthorship W4319072895A5039404681 @default.
- W4319072895 hasAuthorship W4319072895A5042748825 @default.
- W4319072895 hasAuthorship W4319072895A5045542419 @default.
- W4319072895 hasAuthorship W4319072895A5049351697 @default.
- W4319072895 hasAuthorship W4319072895A5053138993 @default.
- W4319072895 hasAuthorship W4319072895A5068750928 @default.
- W4319072895 hasAuthorship W4319072895A5069771802 @default.
- W4319072895 hasAuthorship W4319072895A5071798264 @default.
- W4319072895 hasAuthorship W4319072895A5083003250 @default.
- W4319072895 hasConcept C121608353 @default.
- W4319072895 hasConcept C126322002 @default.
- W4319072895 hasConcept C143998085 @default.
- W4319072895 hasConcept C199374082 @default.
- W4319072895 hasConcept C2775842073 @default.
- W4319072895 hasConcept C2776256026 @default.
- W4319072895 hasConcept C2776694085 @default.
- W4319072895 hasConcept C2776755627 @default.
- W4319072895 hasConcept C2778292576 @default.
- W4319072895 hasConcept C2780790343 @default.
- W4319072895 hasConcept C2989005 @default.